| LM ID |
Analyte |
Treatment |
Time(hrs) |
Sample ID |
Value |
Units |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
0.0 |
BCD100427B002 |
13.1 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
0.5 |
BCD100427B005 |
10.8 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
1.0 |
BCD100427B009 |
12.4 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
2.0 |
BCD100427B013 |
8.49 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
4.0 |
BCD100427B017 |
8.98 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
8.0 |
BCD100427B021 |
11.6 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
12.0 |
BCD100427B025 |
12.7 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
24.0 |
BCD100427B029 |
22.7 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
0.0 |
BCD100427B001 |
13.1 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
0.5 |
BCD100427B003 |
10.9 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
1.0 |
BCD100427B007 |
11.8 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
2.0 |
BCD100427B011 |
8.33 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
4.0 |
BCD100427B015 |
10.5 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
8.0 |
BCD100427B019 |
11 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
12.0 |
BCD100427B023 |
18 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
24.0 |
BCD100427B027 |
15.2 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
0.5 |
BCD100427B006 |
8.35 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
1.0 |
BCD100427B010 |
13.1 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
2.0 |
BCD100427B014 |
9.22 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
4.0 |
BCD100427B018 |
10 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
8.0 |
BCD100427B022 |
15.4 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
12.0 |
BCD100427B026 |
11.6 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
24.0 |
BCD100427B030 |
14.9 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
0.5 |
BCD100427B004 |
12.6 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
1.0 |
BCD100427B008 |
11.5 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
2.0 |
BCD100427B012 |
6.72 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
4.0 |
BCD100427B016 |
8.23 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
8.0 |
BCD100427B020 |
10.6 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
12.0 |
BCD100427B024 |
9.55 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
24.0 |
BCD100427B028 |
14.5 |
pmol/sample |